Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1999 Apr;66(4):490–494. doi: 10.1136/jnnp.66.4.490

Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy

H Palomaki 1, M Kaste 1, A Berg 1, R Lonnqvist 1, J Lonnqvist 1, M Lehtihalmes 1, J Hares 1
PMCID: PMC1736281  PMID: 10201422

Abstract

OBJECTIVES—(1) To test whether early prophylactic antidepressive treatment by mianserin is able to prevent poststroke depression, and (2) to discover whether mianserin as an antidepressant has any beneficial influence on the outcome of ischaemic stroke.
METHODS—A randomised, double blind, placebo controlled study involved 100 consecutive patients under 71 years old admitted to hospital for an acute ischaemic stroke; they were enrolled to receive 60mg/day mianserin or placebo for 1 year. They were examined on admission, and at 2, 6, 12, and 18 months with depression, stroke, and functional outcome scales.
RESULTS—According to DSM-III-R, the prevalence of major depression was 6% at the initial stage, 11% at 1 year, and 16% at 18 months. At no time point did prevalences differ between the treatment groups, nor were differences found in depression scales, although at 2 months a greater improvement from initial assessment on the Hamilton depression scale was evident in patients on mianserin (p=0.05). Some beneficial changes on the Hamilton depression scale and Beck depression inventory were found in patients older than 56 (median age) and in men treated with mianserin, but not in other subgroups. Mianserin treatment did not affect stroke outcome as measured by neurological status, nor did it have any influence on functional outcome as measured by Rankin scale or Barthel index.
CONCLUSION—It was not possible to show that early initiation of antidepressant therapy can prevent poststroke depression, because the prevalence of poststroke depression remained low even in patients on placebo. In this stroke population with a low rate of depressive patients, antidepressive medical treatment failed to affect stroke outcome.



Full Text

The Full Text of this article is available as a PDF (106.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen G., Vestergaard K., Lauritzen L. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke. 1994 Jun;25(6):1099–1104. doi: 10.1161/01.str.25.6.1099. [DOI] [PubMed] [Google Scholar]
  2. Aström M., Adolfsson R., Asplund K. Major depression in stroke patients. A 3-year longitudinal study. Stroke. 1993 Jul;24(7):976–982. doi: 10.1161/01.str.24.7.976. [DOI] [PubMed] [Google Scholar]
  3. Aström M., Asplund K., Aström T. Psychosocial function and life satisfaction after stroke. Stroke. 1992 Apr;23(4):527–531. doi: 10.1161/01.str.23.4.527. [DOI] [PubMed] [Google Scholar]
  4. Burvill P. W., Johnson G. A., Jamrozik K. D., Anderson C. S., Stewart-Wynne E. G., Chakera T. M. Prevalence of depression after stroke: the Perth Community Stroke Study. Br J Psychiatry. 1995 Mar;166(3):320–327. doi: 10.1192/bjp.166.3.320. [DOI] [PubMed] [Google Scholar]
  5. Coulter D. M., Edwards I. R. Mianserin and agranulocytosis in New Zealand. Lancet. 1990 Sep 29;336(8718):785–787. doi: 10.1016/0140-6736(90)93248-n. [DOI] [PubMed] [Google Scholar]
  6. Diamond P. T., Holroyd S., Macciocchi S. N., Felsenthal G. Prevalence of depression and outcome on the geriatric rehabilitation unit. Am J Phys Med Rehabil. 1995 May-Jun;74(3):214–217. doi: 10.1097/00002060-199505000-00006. [DOI] [PubMed] [Google Scholar]
  7. Feighner J. P., Jacobs R. S., Jackson R. E., Hendrickson G., Merideth C. H., O'Meara P. D. A double-blind comparative trial with mianserin and amitriptyline in outpatients with major depressive disorders. Br J Clin Pharmacol. 1983;15 (Suppl 2):227S–237S. doi: 10.1111/j.1365-2125.1983.tb05870.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960 Feb;23:56–62. doi: 10.1136/jnnp.23.1.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hindfelt B., Nilsson O. Long-term prognosis of ischemic stroke in young adults. Acta Neurol Scand. 1992 Nov;86(5):440–445. doi: 10.1111/j.1600-0404.1992.tb05120.x. [DOI] [PubMed] [Google Scholar]
  10. Hunt S. M., McKenna S. P., McEwen J., Backett E. M., Williams J., Papp E. A quantitative approach to perceived health status: a validation study. J Epidemiol Community Health. 1980 Dec;34(4):281–286. doi: 10.1136/jech.34.4.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kalra L., Yu G., Wilson K., Roots P. Medical complications during stroke rehabilitation. Stroke. 1995 Jun;26(6):990–994. doi: 10.1161/01.str.26.6.990. [DOI] [PubMed] [Google Scholar]
  12. Kaste M., Palomäki H., Sarna S. Where and how should elderly stroke patients be treated? A randomized trial. Stroke. 1995 Feb;26(2):249–253. doi: 10.1161/01.str.26.2.249. [DOI] [PubMed] [Google Scholar]
  13. Khan M. C., Bennie E. H., Stulemeijer S. M., Ravens M. A. Mianserin and doxepin in the treatment of outpatient depression with anxiety. Br J Clin Pharmacol. 1983;15 (Suppl 2):213S–218S. doi: 10.1111/j.1365-2125.1983.tb05868.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kopera H. Anticholinergic and blood pressure effects of mianserin, amitriptyline and placebo. Br J Clin Pharmacol. 1978;5 (Suppl 1):29S–34S. [PMC free article] [PubMed] [Google Scholar]
  15. Kotila M., Numminen H., Waltimo O., Kaste M. Depression after stroke: results of the FINNSTROKE Study. Stroke. 1998 Feb;29(2):368–372. doi: 10.1161/01.str.29.2.368. [DOI] [PubMed] [Google Scholar]
  16. Lauritzen L., Bendsen B. B., Vilmar T., Bendsen E. B., Lunde M., Bech P. Post-stroke depression: combined treatment with imipramine or desipramine and mianserin. A controlled clinical study. Psychopharmacology (Berl) 1994 Feb;114(1):119–122. doi: 10.1007/BF02245452. [DOI] [PubMed] [Google Scholar]
  17. Lipsey J. R., Robinson R. G., Pearlson G. D., Rao K., Price T. R. Nortriptyline treatment of post-stroke depression: a double-blind study. Lancet. 1984 Feb 11;1(8372):297–300. doi: 10.1016/s0140-6736(84)90356-8. [DOI] [PubMed] [Google Scholar]
  18. MAHONEY F. I., BARTHEL D. W. FUNCTIONAL EVALUATION: THE BARTHEL INDEX. Md State Med J. 1965 Feb;14:61–65. [PubMed] [Google Scholar]
  19. McGrath P. J., Blood D. K., Stewart J. W., Harrison W., Quitkin F. M., Tricamo E., Markowitz J. A comparative study of the electrocardiographic effects of phenelzine, tricyclic antidepressants, mianserin, and placebo. J Clin Psychopharmacol. 1987 Oct;7(5):335–339. [PubMed] [Google Scholar]
  20. Morris P. L., Raphael B., Robinson R. G. Clinical depression is associated with impaired recovery from stroke. Med J Aust. 1992 Aug 17;157(4):239–242. doi: 10.5694/j.1326-5377.1992.tb137126.x. [DOI] [PubMed] [Google Scholar]
  21. Morris P. L., Robinson R. G., Andrzejewski P., Samuels J., Price T. R. Association of depression with 10-year poststroke mortality. Am J Psychiatry. 1993 Jan;150(1):124–129. doi: 10.1176/ajp.150.1.124. [DOI] [PubMed] [Google Scholar]
  22. Morris P. L., Robinson R. G., Raphael B. Prevalence and course of depressive disorders in hospitalized stroke patients. Int J Psychiatry Med. 1990;20(4):349–364. doi: 10.2190/N8VU-6LWU-FLJN-XQKV. [DOI] [PubMed] [Google Scholar]
  23. Ng K. C., Chan K. L., Straughan P. T. A study of post-stroke depression in a rehabilitative center. Acta Psychiatr Scand. 1995 Jul;92(1):75–79. doi: 10.1111/j.1600-0447.1995.tb09546.x. [DOI] [PubMed] [Google Scholar]
  24. Primeau F. Post-stroke depression: a critical review of the literature. Can J Psychiatry. 1988 Nov;33(8):757–765. doi: 10.1177/070674378803300816. [DOI] [PubMed] [Google Scholar]
  25. RANKIN J. Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J. 1957 May;2(5):200–215. doi: 10.1177/003693305700200504. [DOI] [PubMed] [Google Scholar]
  26. Robinson R. G., Szetela B. Mood change following left hemispheric brain injury. Ann Neurol. 1981 May;9(5):447–453. doi: 10.1002/ana.410090506. [DOI] [PubMed] [Google Scholar]
  27. Schubert D. S., Burns R., Paras W., Sioson E. Decrease of depression during stroke and amputation rehabilitation. Gen Hosp Psychiatry. 1992 Mar;14(2):135–141. doi: 10.1016/0163-8343(92)90039-d. [DOI] [PubMed] [Google Scholar]
  28. Shima S., Kitagawa Y., Kitamura T., Fujinawa A., Watanabe Y. Poststroke depression. Gen Hosp Psychiatry. 1994 Jul;16(4):286–289. doi: 10.1016/0163-8343(94)90008-6. [DOI] [PubMed] [Google Scholar]
  29. Side-effects of nortriptyline treatment for post-stroke depression. Lancet. 1984 Mar 3;1(8375):519–520. [PubMed] [Google Scholar]
  30. Sjögren K. Leisure after stroke. Int Rehabil Med. 1982;4(2):80–87. doi: 10.3109/09638288209166884. [DOI] [PubMed] [Google Scholar]
  31. Stead A. H., Moffat A. C. A collection of therapeutic, toxic and fatal blood drug concentrations in man. Hum Toxicol. 1983 Jul;2(3):437–464. doi: 10.1177/096032718300200301. [DOI] [PubMed] [Google Scholar]
  32. Viitanen M., Fugl-Meyer K. S., Bernspång B., Fugl-Meyer A. R. Life satisfaction in long-term survivors after stroke. Scand J Rehabil Med. 1988;20(1):17–24. [PubMed] [Google Scholar]
  33. Vuori E., Ruohonen A., Penttilä A., Klaukka T., Lahti T. Fatal poisonings with antidepressants in Finland 1985-1987. Acta Psychiatr Scand Suppl. 1989;354:55–60. doi: 10.1111/j.1600-0447.1989.tb03047.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES